China will adjust tariffs on imported U.S. products from 12:01 p.m. Wednesday, the Customs Tariff Commission of the State Council announced on Tuesday.
The immunoassay segment accounts about 35% of the market, with no growth compared to the previous year. Domestic brands account for over 35%.
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
On April 1, Mr. Yu Rong, Chairman of Meinian Onehealth, and his delegation visited the headquarter of Adicon to have a discussion and exchange views on the strategic cooperation and innovative business cooperation between Meinian Onehealth and Adicon.
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2024, which include the consolidated financial results for GRAIL.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal 2024, which ended March 31, 2024.
From April 17 to 26, 2024, Hesheng Wang, Vice Minister of the National Health Commission of the PRC and Director of the National Disease Control and Prevention Administration, led a delegation to visit Germany, Finland and the Republic of Korea.
Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the first quarter of 2024.
Revvity, Inc. (NYSE: RVTY), today reported financial results for the first quarter ended March 31, 2024.
The US Food and Drug Administration released on Monday its final rule to regulate laboratory-developed tests (LDTs).
The fully automatic biochemistry analyzer, characterized by high technical content, high accuracy, high precision, high flexibility, and high working efficiency, has become one of the indispensable instruments in the modern clinical laboratory for the increasing testing work.
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.